Aggressive medical therapy alone is adequate in certain patients with severe symptomatic carotid stenosis

Stroke

Volumn 44, Issue 10, 2013, Pages 2957-2958

  Chaturvedi, Seemant ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carotid endarterectomy; Carotid stenosis

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN;

CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; DRUG MEGADOSE; HUMAN; LIFESTYLE MODIFICATION; NOTE; PRIORITY JOURNAL; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK;

CAROTID ENDARTERECTOMY; CAROTID STENOSIS;

CAROTID ARTERY DISEASES; CONSTRICTION, PATHOLOGIC; HUMANS;

EID: 84888309101     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000918     Document Type: Note

References (4)

1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003.
2. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: A secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39:3297-3302.
3. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233-2240.
4. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915-924.